CONCLUSION: If nail polish is not removed, compliance of these safety levels (SpO 2 : black 99%, purple 98%, and blue 100%) during intensive care routine treatment may help to reduce the incidence of unrecognized hypoxic episodes (e.g. SaO 2 Ͻ 96%).
INTRODUCTION:
Cerebral oximetry, which is based on near-infrared spectroscopy (NIRS) technology, is a non-invasive optical technique that offers continuous real-time monitoring of cerebral tissue oxygen saturation (SctO 2 ). SctO 2 represents the blood oxygen saturation in the microvasculature of brain tissue, which contains a mixture of arterial and venous blood, and reflects the balance between cerebral oxygen supply and demand. A cerebral oximeter (FORE-SIGHT TM , CAS Medical Systems, Branford, CT USA) has been previously validated on neonatal patients during Extracorporeal Membrane Oxygenation (ECMO) (1, 2) . From the data collected in the validation study, we observed the relationship between cerebral oximetry and pulse oximetry measurements.
METHODS: After obtaining informed consent, we used the cerebral oximeter to monitor neonates undergoing veno-venous or venoarterial ECMO. A specially designed neonatal sensor was attached to the subject's left or right forehead. Arterial oxygen saturation (SpO 2 ) data was collected from a Nellcor N-395 (Tyco/Nellcor, Pleasanton, CA USA) pulse oximeter with the sensor placed on the neonate's foot. For the study, cerebral oximetry and pulse oximetry data was collected every 3 seconds. Pre-ECMO surgical event markers were also recorded.
RESULTS: 30 subjects were studied with a total of Ͼ1200 hours of cerebral and pulse oximetry data collected. For the most part, cerebral oximeter SctO 2 and pulse oximeter SpO 2 closely correlated with each other. Typical SctO2 observed values were 65 to 90% during clinically stable conditions, with observed typical SpO 2 values of 88 to 100%. SctO 2 values tended to be 20 -30% lower than SpO 2 because cerebral oximetry interrogates mostly venous blood in the microvasculature of the brain. During certain clinical situations, pulse oximetry was either less sensitive to brain oxygenation changes compared to SctO 2 , or did not function reliably during low perfusion conditions such as circulatory arrest leading to the application of cardiopulmonary resuscitation (CPR). The case study shown in Fig. 1 is one example where pulse oximetry was intermittently functional, while cerebral oximetry continued to be reliable during CPR. Other cases show that during hyperemia or increased FiO 2 , cerebral oximetry SctO 2 was sensitive to brain oxygenation changes while pulse oximetry was not able to measure changes because arterial oxygen saturation was at 100%.
CONCLUSION: Current use of real-time non-invasive pulse oximetry to monitor arterial blood oxygenation is often unreliable during low perfusion events, especially during circulatory arrest because of diminished or cessation of pulsatile blood flow. Also, pulse oximetry is not a direct indicator of brain oxygenation. Cerebral oximetry offers a direct method to measure cerebral saturation and potentially predict brain injury caused by an impaired balance between cerebral oxygen supply and demand. These results demonstrate the value of cerebral oximetry to monitor the effectiveness of CPR in situations where pulse oximetry is unreliable. Cerebral oximetry is a promising modality for bedside monitoring in the NICU and is complementary to pulse oximetry.
In clinical settings, the accuracy of pulse oximeter sensors is often presumed, even when the sensor is used "off-label" in alternative locations such as the ear, cheek, tongue, forehead, or nasal septum. Although Spo 2 data can often be obtained from Photograph of the pediatric/neonatal esophageal pulse oximetry probe. these malpositioned sensors, to date, no studies have demonstrated whether such usage is accurate across the full range of saturation. This study compared the accuracy of malpositioned sensors with their properly placed counterparts, using a properly placed forehead sensor as reference (Nellcor Max Fast sensor, A RMS Ͻ 2.0). Sensors examined in this study focused on disposable digit sensors (Nellcor Max-A, Masimo LNOP-Adt, Nonin 7000A, and the Datex Ohmeda Oxy-Tip) placed on the ear, forehead, or cheek, and reusable sensors (Nellcor DS100-A, Masimo LNCS, Nonin 8000A) placed sideways on a digit. The protocol used to assess Spo 2 across a range of saturations followed standard methodology recommended by ISO 9919.
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Results demonstrate that regardless of sensor make or type, Spo 2 reading accuracy is no longer maintained when sensors are malpositioned. This is increasingly obvious at lower saturation levels. In a 2 analysis of the number of readings within 2% Spo 2 compared with the reference sensor readings (A), between 2% and 5% (B), and greater than 5% (C), every malpositioned sensor had more readings in the B and C category than their properly placed counterparts (P Ͻ 0.001). The increase in A RMS for all sensors was statistically significant when sensors were malpositioned (P Ͻ 0.05), with the exception of the Masimo LNOP-Adt (P ϭ 0.059). The results from the present study highlight the importance of placing the sensors properly, especially in patients at risk of desaturations.
Pulse Oximeter Sensor Accuracy
V. Hickson, and G. Mathews From The Electrode Company Ltd., Llangwm, UK
SUMMARY: Pulse oximetry is used worldwide every day and is often influential in clinical decisions. Brave talk about leading edge medical technology gives the impression of thoroughly reliable systems, completely compliant with regulatory requirements. This is a misleading picture. It is as if pulse oximeter sensors are an embarrassing detail that has been overlooked. Pulse oximeter system accuracy is very dependent on sensor accuracy. Sensor accuracy is dependant on the spectral properties of the sensor being the same as those used during the clinical trials. All too often, this is not the case.
One thousand and eight sensors from 36 hospitals were surveyed. Thirty percent of these sensors were a cause for concern. Seventeen percent of the sensors surveyed had wavelength errors with corresponding SATs value errors capable of compromising patient safety.
PURPOSE:
To investigate the implications of variations in pulse oximeter sensor optical characteristics on patient safety.
METHOD:
A specialized spectrometer was used to determine the wavelength errors in pulse oximeter sensors. A wavelength error is defined as the difference between the expected wavelengths and the observed wavelengths.
The effect of wavelength errors on the calculated SATs value that would be displayed on the monitor was calculated at patient SAT values of 97%, 90%, 80%, and 70%.
The data were obtained from sensors either in use or held as spares in hospitals. The sensors included both disposable and reusable sensors from most manufacturers including both Original Equipment Manufacturers and Third Party Manufacturers.
RESULTS:
One thousand and eight sensors were studied from 36 hospitals. Sensors with circuit faults and faulty optical components were noted, and accuracy data only taken from apparently functional sensors. Thirteen percent of the sensors had circuit faults. Seventeen percent of the sensors were apparently functional, but had SATs value errors of 4% or more.
DISCUSSION:
When making accuracy claims the manufacturer has to allow for not only the biological variability between patients, but also any systematic errors introduced by variations in the sensor spectral properties. Often quoted accuracy claims for pulse oximetry allow for biological variability with little room for sensorrelated systematic bias. In plain words, sensors of the same type, when used on the same person, should all read the same. However, in practice, they do not all read the same.
Only 14% of the sensors surveyed had no error, thus leaving 86% with errors of some sort. Seventeen percent of the sensors surveyed had SATs value errors of 4% or more. This is a systematic error with no component for biological variability, and such an error results in the pulse oximeter system failing to work as the manufacturer claims, and increases the risk of an adverse incident.
High-reading sensors can result in oxygen therapy being deferred or not given. Low-reading sensors can result in excessive oxygen therapy being given. Inappropriate oxygen therapy can lead to outcomes ranging from metabolic disturbances to death.
Changes in users expectations are putting greater demands on pulse oximetry. Some claim that new generation pulse oximeters can help reduce the incidence of ROP, but this is only if the accuracy of the sensors can be guaranteed. More patients are being treated while in hypoxia, large errors at low SATs compromise patient safety. The progress of many patients is recorded by monitoring trends in SATs values by spot checks. The value of this data depends on minimal variability between sensors.
Some believe that CE marking and FDA clearance are guarantees of sensor accuracy, but this belief is unfounded. In practice, mismatches between sensor spectral properties and the R curve in the monitor are putting patients at risk from the perils of excessive or insufficient oxygen therapy.
CONCLUSION:
The accuracy of a pulse oximeter system is very dependant on the accuracy of the sensor. The accuracy of the sensor is largely dependant on the optical characteristics of the sensor matching the R curve in the monitor.
Not all sensors match the R curve in the monitor that they are used with. The data shows that variations in sensor spectral properties result in pulse oximeters not functioning as the manufacturers claim. Within the 36 hospitals surveyed, 30% of the sensors surveyed had unacceptable faults, including 17% of sensors with SATs errors of sufficient magnitude to compromise patient safety. Clinicians have come to rely on pulse oximeters. In good faith, judgments are based on the data they give.
The reliability of the data is very dependant on the accuracy of the sensor. If it is not known that the LEDs in the pulse oximeter sensor are within specification, every clinical decision made that is based on the data is without foundation.
Estimation of Pulse Oximetry Safety-Levels for Patients with Nail Polish Applied
J. Hinkelbein,* H.V. Genzwuerker,* and F. Fiedler* † From the *University Clinic for Anesthesiology and Intensive Care Medicine, Medical Faculty of Mannheim, University Hospital Mannheim, 68167 Mannheim, Germany; and †Clinic for Anesthesiology and Intensive Care Medicine, Krankenhaus St. Elisabeth, Cologne, Germany
BACKGROUND: Nail polish of dark colors has repeatedly been reported to interfere with pulse oximetry (1, 2) readings. Therefore, readings may deviate from the gold standard co-oximetry leading to a risk for unnoticed hypoxia. The aim of this study was to estimate three different pulse oximetry safety levels for critically ill patients with black, purple, or blue nail polish applied.
MATERIALS AND METHODS:
After approval of the local ethics committee and guardian approval, three different nail polishes (black, purple, and blue) were applied standardized in two layers on finger nails in 50 critically ill and mechanically ventilated patients of an intensive care unit (ICU). Oxygen saturation was determined simultaneously by pulse oximetry (SpO 2 ; Siemens SC1281, Siemens Medical Electronics, Danvers, USA) and co-oximetry (SaO 2 ; Radiometer Copenhagen ABL System 625, Brønshøj, Denmark). The safety levels for each color were determined by graphical analysis of the correlation between SaO 2 (x-axis) and SpO 2 (y-axis) as previously suggested by Seguin et al. [3] . The safety-level (i.e. the SpO 2 needed) to guarantee a SaO 2 of 96% was determined on the basis of an error probability of ␣ ϭ 5%. 
RESULTS
INTRODUCTION:
Interhospital transportation (IHT) of critically ill and mechanically ventilated patients represents a common, yet difficult, problem. Three different methods to determine Pco 2 during IHT are feasible in clinical routine: arterial blood gas analysis with mobile analyzers (Paco 2 ), end-tidal (Petco 2 ), and transcutaneous (P tc co 2 ) measurement. The aim of the present study was to compare accuracy and precision of these three methods simultaneously in critically ill and ventilated adults during IHT.
METHODS:
Patients scheduled for interhospital transport were investigated after written informed consent and approval of the local ethics committee in this prospective clinical study. Pco 2 was determined five times in each patient during the transport simultaneously by 1) arterial blood gas analysis (PAco 2 [IRMA], IRMA®, mobile analyzer, Diametrics Inc., St. Paul, USA), 2) end-tidal measurements with capnography (Petco 2 , Propaq 106 EL Monitor, Protocol Systems Inc., Beaverton, USA), and 3) transcutaneous measurements (p tc co 2 , Radiometer Copenhagen, Brønshøj, Denmark). The data obtained during transportation were compared with an in-hospital reference measurement (PAco 2 [ABL625]) as gold standard (ABL 625, Radiometer Copenhagen, Brønshøj, Denmark). For statistical analysis of accuracy (bias, systematic error) and precision (random error) a Bland-Altman analysis was performed. A P Ͻ 0.05 was considered statistically significant. 
RESULTS
CONCLUSIONS:
During IHT Paco 2 [IRMA] and P tc co 2 provide the best accuracy when compared with the reference measurement. For patients who either require a tight control of Pco 2 or endured lengthy transportation, capnography alongside arterial blood gases or the transcutaneous measurement of Pco 2 could be useful.
Artificial Acrylic Finger Nails May Interfere with Pulse Oximetry
J. Hinkelbein,* H. Koehler,* H.V. Genzwuerker,* and F. Fiedler* † From the *University Clinic for Anesthesiology and Intensive Care Medicine, Medical Faculty of Mannheim, University Hospital Mannheim, Mannheim, Germany; and †Clinic for Anesthesiology and Intensive Care Medicine, Krankenhaus St. Elisabeth, Cologne, Germany
INTRODUCTION: Pulse oximetry is the most common technique to monitor oxygen saturation (Spo 2 ) during anesthesiology, emergency medical treatment, and intensive care therapy. However, intermittent cooximetry with a hemoximeter (Sao 2 ) is still the "gold standard" to validate Spo 2 measurements. Numerous influencing factors have been reported to interfere with pulse oximetry and may result in faulty readings. One of these factors is artificial acrylic finger nails. Clinical data on this topic are not sufficiently published.
METHODS:
After approval of the local ethics committee and informed consent, a prospective clinical study in mechanically ventilated and critically ill patients of an intensive care unit (ICU) was performed. Patients were randomly assigned to either group S (S ϭ Siemens pulse oximeter) or group P (P ϭ Philips pulse oximeter) before the measurements. Spo 2 was determined in each patient three times alternately in standard ( N Spo 2 ) and sideways position at the natural nail ( N90 Spo 2 ). For the reference measurements, oxygen saturation was measured by means of cooximetry (Sao 2 ). Thereafter, Spo 2 was obtained at the acrylic finger nail in the same way ( A Spo 2 and A90 Spo 2 ). Bias was calculated as [Delta]S ϭ N Spo 2 Ϫ Sao 2 and [Delta]S ϭ A Spo 2 Ϫ Sao 2 . Accuracy (mean difference) and precision (standard deviation) were used to determine the measurement discrepancy. For statistical analysis, the t-test was used. P Ͻ 0.05 was considered significant.
RESULTS:
A total of n ϭ 46 critically ill and mechanically ventilated patients (14 female and 32 male) were investigated. Accuracy and precision without acrylic nails applied were comparable to Sao 2 in both groups (group S: [Delta]S ϭ Ϫ0.7% Ϯ 2.51%, group P:
[Delta]S ϭ ϩ0.6% Ϯ 2.77%; each n.s. and n ϭ 23). With acrylic nails applied a bias of [Delta]S ϭ Ϫ1.1% Ϯ 3.14% for group S (P ϭ 0.005) and a bias of [Delta]S ϭ ϩ0.8% Ϯ 3.04% for group P (n.s.) was calculated.
CONCLUSION: This is the first clinical study analyzing pulse oximetry accuracy and precision in patients with artificial acrylic finger nails present. Acrylic finger nails may impair the measurement of oxygen saturation depending on the pulse oximeter used and may cause significant inaccuracy. Hence, removal of artificial acrylic finger nails may be helpful to assure an accurate and precise measurement with pulse oximetry.
Optimizing Conditions for Acquiring and Understanding Oxygenation Data in a Clinical Setting
Robert J. Kopotic, MSN, FAARC From the ConMed Corporation, Utica, New York
INTRODUCTION: Two large, nondevice industry-sponsored studies suggest that pulse oximeters lack the accuracy claimed by their manufacturers for Spo 2 values in neonates and adults during routine clinical use (1, 2 oximeters by using data from healthy adults. These test subjects are trained to breathe hypoxic gas mixtures to achieve oxygenation plateaus. Reference material is available to assist the clinician in their quest to optimize conditions for acquiring and understanding oxygenation data (3) (4) (5) (6) (7) (8) .
METHODS:
The following table was distilled from the reference material and categorizes the user action and rationale affecting various aspects of device performance. The figure that follows illustrates the idealized laboratory conditions for comparison of blood gas and pulse oximetry data.
CONCLUSION:
The accuracy claims by manufacturers of pulse oximeters are better than the performance experienced in clinical care. Trained users with improved device instructions that better care for the instrumentation can improve correlation of blood gas and pulse oximetry data in the clinical setting.
Shortcomings for Achieving Laboratory Quality Blood Gas and Pulse Oximetry Data in the Clinical Setting
Robert J. Kopotic, MSN, FAARC From the ConMed Corporation, Utica, New York
INTRODUCTION: Data suggest that pulse oximeters in routine clinical use lack the accuracy claimed for Spo 2 values by their manufacturers for adults and neonates. A metaanalysis of 74 studies on adults revealed a dramatic difference in Spo 2 to Sao 2 correlation between "healthy adult volunteers" and "critically ill/ICU patients," r ϭ 0.96 and 0.76, respectively (1). In clinical use (i.e., not laboratory testing), use of 21 oximeter models had a range of Spo 2 to Sao 2 correlation from 0.99 to 0.59, with variability found even within the same model. A multicenter study of acutely ill neonates compared nearly 32,000 data sets of Sao 2 to Spo 2 values collected during routine care (2) . Multiple brands of CO-oximeters (ABL, Beyer and Instrumentation Laboratory) and pulse oximeters (Datex-Ohmeda, Masimo, Nellcor and Spacelabs) were used. None of the pulse oximeters provided a consistent bias or precision of Spo 2 values across the range of Sao 2 of 70%-100%. The authors' concluded, pending improvement in Spo 2 accuracy, adjustments to supplemental oxygen and ventilator settings in the NICU patient "must be based on and reevaluated by arterial blood analysis." Clearly, there is more "noise" than "signal" with pulse oximetry data in clinical environs.
Optimizing Comparison of a CO-Oximetry SaO 2 Value with Pulse Oximetry (PO) SpO 2 Values in Clinical Care
User action Rationale
Expose the stopcock used for sampling arterial blood but avoid noise, touch and movement of bedding.
Exposure to cold, noise or touch can startle patient with change of their resting state, respiratory and cardiac rhythmicity. Observe the PO sensor to be certain it is well aligned, secured and generating maximize signal quality.
A misaligned or loose sensor will reduce PO performance and signal quality.
• Before sampling blood, assure stability of patient's data condition ͓Spo 2 (Ϯ2%) and PR (Ϯ3 bpm) values͔ for at least 90 s.
Stability in PO data is essential for Sao 2 comparison. Typically, the circulatory path is traversed by a RBC in 60 s so allowing 90 s of stable Spo 2 should assure a matching Sao 2 . Also, equilibrium is required to overcome monitor averaging time.
• Note anything during blood sampling that is likely to adversely affect the Spo 2 and pulse rate values (e.g., change in breathing, change in supplemental oxygen or mechanical ventilator setting). Assure complete removal of the nonblood fluid (e.g., flush solution) from the arterial catheter and sampling line for at least two times the dead space volume.
The specimen must contain solely arterial blood. Hemodilution and various nonblood fluids (e.g., hyperalimentation and lipids) can alter Sao 2 accuracy. Sample blood slowly.
Exposing whole blood to vacuum can outgas CO 2 and O 2 thereby altering Paco 2 and Pao 2 , hence Sao 2 . Express any air bubbles and cap the syringe.
Air is a contaminant and can alter Paco 2 and Pao 2 , hence Sao 2 . Agitate specimen just before analysis.
A homogenous blood sample is ideal. Analyze the blood within 2 min of sampling.
RBC metabolism continues in a stored specimen, thereby altering pH, Paco 2 and Pao 2 , hence Sao 2 . This is especially true in leukocytosis, where the Po 2 can drop more than 50% within 2 min of sampling. Visualize and record the bedside ECG HR, Spo 2 and PR values.
Timely data capture reduces error.
Record Sao 2 findings, using the functional not fractional Sao 2 value.
Functional Sao 2 is reference for Spo 2 .
The clinical setting often contains many facets that adversely affect pulse oximeter performance: 
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ANESTHESIA & ANALGESIA METHODS: The following table summarizes the differences in the clinical and laboratory settings known to affect device performance. The figure that follows illustrates the sources of "noise " found in clinical care with blood gas and pulse oximetry data.
CONCLUSION:
Pulse oximeter manufacturer accuracy claims are better than those found in clinical studies. This discrepancy is likely owing to data of healthy volunteers with skilled technicians in controlled laboratory conditions versus clinicians collecting patient data in the chaos of clinical care. Knowing and compensating for the device and setting limitations should improve correlation of blood gas and pulse oximetry data for clinicians.
Uses of Software Interfaces in the Study of Commercial Medical Devices
Raymond Kozikowski, BSEE,* Andrew Winslow,* and Allan Shang, MD, MSE* † From the *Pratt School of Engineering, Duke University; and †Department of Anesthesiology, Duke University Med. Ctr., Durham, North Carolina
INTRODUCTION: Advances in technology have allowed for rapid development of new and improved clinical monitoring devices. As important as the swift development of technology is the expeditious development of methods for analyzing and evaluating the accuracy and safety of this technology. An important secondary goal for these analytical methods and data collection systems is to integrate patient data into usable and meaningful displays in order that scientist and clinicians can evaluate multiple systems or patients at a glance. One highly useful tool for collecting and analyzing data is LabVIEW®, an object-oriented language that allows for the creation of virtual instruments. These programs are Graphical User Interfaces that the researcher can manipulate to modify the program options and displays. The "front panel" also allows for simultaneous visual display of real-time data from multiple devices. LabVIEW is also optimized for the control, interface, and automation of instrumentation. Further, the nature of the LabVIEW environment lends itself to the real-time processing of data, which can also be simultaneously displayed with the raw data. Raw and processed data can then be recorded in Excel ® spreadsheets for additional analysis and evaluation.
Another attractive feature of this language is the ease with which applications can be developed. Prototypes can be built using the using the prepackaged tools or a custom hierarchy can be developed. The "dataflow" nature of the environment makes it ideal for a "test-as-you-go" approach to application development. This type of development makes accurate development easy and requires very little troubleshooting in the final stages of prototyping (1) .
A particular area of interest is in the collection of pulse oximetry data. Currently our group has several ongoing studies that would be impossible without the aid of LabVIEW. One of these studies is the characterization of motion artifact via plethysmographic signals (2) . Another study is underway to compare the accuracy of pulse oximeters in pediatric patients with low saturations (3) . Three particular challenges that LabVIEW allows these studies to address are time correlation of data, integration of multiple streaming data sources, and the comparison of data from different types of devices. The pediatric study requires up to four time-stamped data streams collected in parallel. The data are time correlated for precision data analysis. Figure  1 below shows the front panel used in this experimental setup.
The motion artifact study uses even more of LabVIEW's resources. The protocol calls for the collection, processing, and display of realtime, raw plethysmographic data. This data streams considerably faster and must retain its temporal signature; otherwise, it will not be useful.
At the same time, as shown in Figure 2 , there is considerable feedback into the front panel of the program. This allows for considerable runtime functionality in the program, all while live data are being collected, displayed, and analyzed. Figure 3 shows the collection of live plethysmographic data and oxygen saturation data. Precision timing in LabVIEW allows for the analysis of this plethysmographic waveform when oxygen saturation is low.
The examples presented here focus on leveraging the technology provided by LabVIEW to improve the ability of scientists to collect reliable data and perform data collection and analysis techniques previously impossible with traditional mean of hand and automated data collection systems. Our simple experiments hardly begin to scratch the surface of the capabilities of this resource. As long as devices are capable of generating digital output, and have some sort of data output port, LabVIEW should be considered as a viable and valuable tool in scientific research. (1) . The aims of the present study were 1) to evaluate the performance of the test protocol and 2) to observe the reliability and functionality of pulse oximeters with respect to the presence of manually and mechanically generated motion artifacts and induced desaturation.
METHODS: Motion was generated both mechanically via a table (Fig. 1) and manually by the subject. The movements are categorized in three patterns: scratching, tapping, and squeezing. Scratching and tapping are performed both manually and mechanically, whereas squeezing is done only by the subject by compressing a soft ball (Fig. 2) .
With the approval of the Ethics Committee of the Medical University of Luebeck and written informed consent, four healthy volunteers (2 male, 2 female, 26 -34 yr of age) participated in the study. Hypoxemic state was induced by breathing a mixture of air with reduced oxygen content through a tight fitting face mask. Vital parameters such as ECG, inspiratory and expiratory oxygen, and carbon dioxide content were continuously monitored.
We used the left hand as the reference hand, which remained motionless, and the volunteer's right hand as the test hand, which was subjected to motion. The hands were positioned at heart level and identical sensors and pulse oximeters were applied to the same fingers on the test hand and the reference hand. To maintain the position of the sensor during motion, adhesive digit sensors were used and an opaque cover to avoid interference with ambient light.
PROCEDURE:
For each motion category, we established a rapid deand resaturation procedure (Fig. 3 ).
Before and after each de-or resaturation period, there was 1 min on a stable plateau--controlled with the reference PO--for test PO signal recording, followed by a 2-min break without movement (detailed protocol Fig. 4 ). The subject's oxygen saturation started at 100% and was rapidly decreased to approximately 70% and held constant for about 4 min. Then, resaturation was induced back to 100% and held constant for about 4 min. This program was repeated five times with the scheduled motion categories.
RESULTS: Data of both reference oximeters and those under test have been recorded and analyzed continuously. All pulse oximeters tested showed similar patterns in curve progression. The test PO randomly lost track of signal and showed zero reading. This artifact caused a false alarm to be displayed. For the test versus the control Spo 2 , the accuracy A rms (root-mean-square of the differences) was calculated (see the following table for details). A rms increased when the subject performed active movements.
DISCUSSION:
The evaluation of pulse oximeter performance under conditions of motion and hypoxemic state has been demonstrated. The protocol presented introduces both the motion and the rapid change of saturation under standardized and repeatable conditions. REFERENCE 
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ANESTHESIA & ANALGESIA surface mount emitter (880 and 655 nm) and a surface mount photodetector mounted between the emitters (Fig. 1) . The probe was designed to be small enough to slide down the lumen of a plastic transparent disposable size 12F (external diameter of 3.8 mm) nasogastric tube. A processing system was constructed to preprocess, record, and display esophageal PPG signals and estimate Spo 2 values on a laptop computer. PPG signals were analyzed by a virtual instrument (VI) implemented in LabView. Algorithms (1) were also developed in the VI for the online estimation of esophageal Spo 2 .
Patients and Measurements. Local research ethics committee approval was obtained for this proof-of-concept pilot study. Five neonates (3 M, 2 F) were studied on the neonatal and pediatric intensive care units. The age range (days), Ϯ sd was (5 to 1398, Ϯ606) and the weight range (kg), Ϯ sd was (1.9 to 10.0, Ϯ3.3). The esophageal probe was advanced gently through the mouth to a maximum depth of 15 cm from the lips. The babies were all mechanically ventilated and adequately sedated. The probe was withdrawn slowly until PPG signals with high signal-to-noise ratio could be obtained. The probe was then left at this depth for the duration of the study for approximately 10 min, and PPG traces and derived Spo 2 values were recorded. During the esophageal measurements, Spo 2 values from a commercial toe pulse oximeter (Philips, Merlin CMS Monitors, Reigate, UK) were also recorded for comparison.
RESULTS: Good quality PPG signals from the esophagus were recorded in all patients. The measured effective signal-to-noise ratio was always better than 40 dB at the output of the system. A total of 48 pairs of Spo 2 values from the five patients were used to compare the esophageal and the commercial toe pulse oximeters. The limits of agreement between the esophageal Spo 2 results and those from the commercial toe pulse oximeter, were calculated using the between-method differences analysis outlined by Bland and Altman (2) . The bias, estimated by the mean difference (d) was Ϫ0.34% and the standard deviation (s) was 0.67%. The limits of agreement for the Spo 2 data (commercial toe and esophageal) were:
CONCLUSIONS:
A new reflectance esophageal pulse oximetry probe and an isolated processing system have been developed, which allow measurements to be made within the esophagus of neonates and children. In this preliminary study, it has been shown that good quality esophageal PPG signals with large amplitudes can be measured within the esophagus of neonates. This appears to be the first report of PPG signals from the esophagus of neonates. In a direct comparison between the esophageal and commercial pulse oximeters, using Bland and Altman analysis, the preliminary Spo 2 results from the two instruments were in good agreement. This study suggests that the esophagus can be used as an alternative site for Spo 2 monitoring in neonatal and pediatric patients and encourages more extensive and rigorous clinical trials.
Photoplethysmography and Blood Oxygen Saturation During Blood Pressure Cuff-Induced Hypoperfusion
P.A. Kyriacou,* K. Shafqat,* and S.K. Pal † From the *School of Engineering and Mathematical Sciences, City University, London, UK; and †St. Andrew's Centre for Plastic Surgery and Burns, Broomfield Hospital, Chelmsford, Essex, UK
PURPOSE: The primary aim of this pilot study was to investigate the morphology and amplitude of the photoplethysmographic (PPG) signal and its effect on blood oxygen saturation (Spo 2 ) under controlled vasoconstriction.
METHODS:
A reflectance finger PPG/Spo 2 probe was constructed comprising two infrared and red emitters and a photodetector. A processing system was also developed (1,2) to detect and preprocess the PPG signals. Blood oxygen saturation values were also obtained using a commercial transmittance finger pulse oximeter (Diascope 2 VISMO; S&W Medico Teknik). PPG traces from the custom-made pulse oximeter and Spo 2 traces from the commercial pulse oximeter were digitized by a 16-bit data acquisition card. A virtual instrument (VI) implemented in LabView was used for the displaying and storing of all acquired signals. The digitized signals were analyzed offline in Matlab 6.5.
The institutional Ethics Committee approved this study, and all subjects gave written consent for participation. Fourteen healthy volunteers, mean age, Ϯ sd (28 Ϯ 5.2) participated in this study. Volunteers were told to rest comfortably in the supine position in an examination table for 3 min to obtain a stable hemodynamic period. The cuff of the sphygmomanometer was then placed on the left arm at the level of the brachial artery. The custom-made reflectance finger PPG/Spo 2 probe was placed on the index finger of the left hand and the commercial pulse oximeter was placed on the ring finger of the same hand. Hypoperfusion was induced by gradually occluding the brachial artery at increments of 10 mm Hg (10 -15 s per pressure increment). During the gradual hypoperfusion process, all parameters were monitored and recorded.
RESULTS:
Measurable PPG traces were obtained in all volunteers in all pressures taken before complete arterial occlusion where the finger PPG signals ceased due to no blood flow to the finger. Figure  1 gives the mean (sd) of the ac infrared PPG amplitudes at the different pressure increments. A Kruskal-Wallis one way analysis of variance on ranks test showed that there were statistically significant differences between the ac PPGs in the low pressures (0 -80 mm Hg) than those in the upper pressures (90 -150 mm Hg) at both wavelengths. The Spo 2 values from both pulse oximeters were decreased gradually as the cuff pressure increased. With the systematic occlusion of the brachial artery, the volume of blood reaching the finger was decreased and that was obvious from the changes in the amplitude of the ac PPG signal from the custommade finger probe. In many occasions, the commercial pulse oximeter failed to give any saturation values after the release of the cuff for approximately 100 s, where the custom-made probe was able to estimate Spo 2 immediately after the cuff was released.
Mean infrared ac PPG amplitudes (sd) at various pressure increments.
Photograph of the pediatric/neonatal esophageal pulse oximetry probe.
Vol. 105, No. 6, December 2007 DISCUSSION AND CONCLUSION: Good quality PPG signals with large amplitudes were measured at all induced pressures before complete occlusion of the brachial artery in all volunteers. During hypoperfusion, the amplitude of the PPG signals were decreased gradually to the point that were not visible. The decrease in the amplitude of the PPG signals correlated well with the decrease in Spo 2 . This is in agreement with the physiological phenomenon that suggests that during arterial vessel stenosis the volume of blood decreases with a direct effect on Spo 2 values measured at a vascular site downstream from the stenosis. The custom-made finger pulse oximetry was found to be more sensitive to Spo 2 changes during induced hypoperfusion when compared with the commercial pulse oximetry. Additional clinical studies, in a group of patients with peripheral vascular disease, are suggested to investigate such a phenomenon further.
Accuracy of a Novel Bioacoustic Sensor in Adult Postoperative Patients with and Without Lung Disease
M. Macknet, MD, P. Kimball-Jones, MD, R. Applegate II, MD, R. Martin, MD, and M. Allard, MBChB, FRCA From the Department of Anesthesiology, Loma Linda University, California
INTRODUCTION: Monitoring respiration of spontaneously breathing patients with chronic obstructive lung disease(COPD) is a concern in a variety of clinical areas including the operating room, postanesthesia care unit (PACU), and on the general care wards. The respiratory status of these patients requires careful vigilance, as they may demonstrate particular sensitivity to analgesics and postoperative pain medications. Most current devices to monitor respiration are limited because they require either a cannula system positioned in line with airflow to detect respiration or impedance pneumography, which is prone to missing obstructive apnea (1) . A novel bioacoustic sensor for continuously monitoring respiration has been developed. We evaluated the accuracy of the prototype sensor in adult postoperative patients with and without COPD in the postanesthesia care unit.
METHODS:
After institutional IRB approval and informed consent, 30 postoperative patients, 19 without lung disease and 11 with COPD, upon arrival to the PACU, were enrolled in this study. All patients were monitored in the standard fashion; in addition, a nasal cannula was placed, secured with tape, and connected to a BCI capnometer (SIMS, Waukesha, WI). An adhesive bioacoustic sensor connected to a breathing frequency monitor prototype (Masimo Corp., Irvine, CA) was applied to the patient's neck just lateral to the cricoid cartilage. Both the capnometer and the bioacoustic monitor were connected to a computer for continuous data recording and subsequent data analysis. The accuracy of the new acoustic sensor and the capnometer were compared with a reference respiratory rate from a manual scoring system. Bias, precision, and A RMS were calculated in the usual fashion, as either bioacoustic sensorreference or capnometer-reference.
RESULTS:
All data are expressed as mean Ϯ sd. Nineteen patients without lung disease (age ϭ 54.6 Ϯ 20.7 yr) and 11 patients with COPD (age ϭ 51.1 Ϯ 9.8 yr) were enrolled. Duration of monitoring time in PACU was 58.2 Ϯ 36.9 min. Respiratory rate varied 3-28 bpm during this time. For the patients without lung disease, the resultant bias, precision, and A RMS for the capnometer compared with the reference value was Ϫ0.48, 2.20, and 2.25, and bioacoustic sensor compared with the reference sensor was 0.04, 2.43, and 2.43, respectively. For the patients with COPD, the resultant bias, precision, and A RMS for the capnometer compared with the reference value was Ϫ0.31, 2.46, and 2.48, and bioacoustic sensor compared with the reference sensor was 0.01, 2.76, and 2.76, respectively.
CONCLUSION:
The new prototype bioacoustic respiratory sensor demonstrates accuracy for respiratory rate monitoring as good as capnometry in PACU patients with and without COPD. This data suggests the new bioacoustic sensor may provide a system at least as accurate as capnometry for monitoring respiration in spontaneously breathing patients with and without COPD. This device offers multiple benefits over existing devices and has a potential to improve monitoring of both healthy patients and patients with lung disease in a general care setting. Macknet, MD, S. Norton, MD, P. Kimball-Jones, MD,  R. Applegate II, MD, R. Martin, MD, and M. Allard 
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ANESTHESIA & ANALGESIA between Hb and SpHb and the regression analysis. The y intercept is 0.62, the slope is 0.954, and the correlation coefficient is 0.882.
DISCUSSION:
This device is the first device developed that can continuously and noninvasively measure hemoglobin concentration, in addition to the other common hemoglobin species, and therefore provides a significant expansion of existing physiologic monitoring technology. Rapid measurement of hemoglobin would be an extremely useful tool in many clinical scenarios. This technology in combination with methemoglobin and carboxyhemoglobin measurements should allow for significant advances inpatient care. P.D. Mannheimer, PhD,* R.E. St. John, MSN, RN, RRT,*  P. Batchelder, LRCP, RRT, † and H. Gehring, MD ‡   From the *Nellcor, Pleasanton, California;  †Clinimark, Golden, Colorado; and 
Pulse Oximeter Accuracy: Multiple-Laboratory Evaluation
‡University of Lü beck, Germany
INTRODUCTION: Validating pulse oximeter saturation (Spo 2 ) accuracy requires comparison to the true arterial oxygen saturation (Sao 2 ) across the full specification range. Although methods are standardized (1), information comparing results among multiple laboratories is limited. We evaluated accuracy of five sensor/monitor configurations at three facilities.
METHODS: Independent data collection was performed at Nellcor's performance testing laboratory in Pleasanton, CA; Clinimark Laboratories, Golden, CO; and at the University of Lü beck, Lü beck, Germany. Each facility used the same general methodology for testing as described by ISO 9919 (1) . After their respective IRB approved protocols and informed consent, pulse oximeter Spo 2 readings obtained on healthy adult volunteers were compared to arterial blood Sao 2 assessed by CO-Oximetry over the range Յ70%-100% Sao 2 during normal perfusion and nonmotion conditions. Two manufacturers' systems were included (Nellcor OxiMax® N-600™, Nellcor, Pleasanton, CA; Masimo Radical®, Masimo Corporation, Irvine, CA). Each system was tested with multiple sensor designs (Table 1) .
Digit sensor placement was rotated among subjects in a balanced design. Each subject had an indwelling arterial catheter for periodic sampling and was exposed to progressive stepwise hypoxic air/nitrogen mixtures to attain the specified saturation range. Stable Spo 2 levels were maintained to ensure tissues at the pulse oximetry sensor site were at the same Sao 2 as found at the radial artery sampling site.
Data Analysis. Computation spans were adjusted for data inclusion to provide a comparable data density over the lower (Յ85%) and upper (Ͼ85%) Sao 2 ranges as suggested in ISO 9919. Accuracy (root-mean-square of the Spo 2 to Sao 2 differences, ARMS) was determined for each system. Occurrence of Spo 2 -SaO2 Ͼ 4% over the range 70%-100% SaO 2 was compared with an expected 95% count of observations (consistent with an ARMS ϭ 2%) using the Fisher's exact test to determine significance (P Ͻ 0.05).
RESULTS:
Thirty-seven subjects spanning a range of age, gender, weight, and skin pigmentation were studied, with 1259 data pairs collected (Table 2) . A, B, and C performed at the Յ2% A RMS level in each California and Germany; Colorado results imply A RMS Ͼ 2% with C data statistically significant (P Ͻ 0.001).
Systems D and E exceeded 2% A RMS at all three facilities (P Ͻ 0.001 California/Germany; Colorado: P ϭ 0.012 (D), E ϭ N.S.). Accuracy for each system was better in the upper saturations than the lower 70%-85% Sao 2 span. System differences were greatest in the lower span, particularly as observed in California and Germany.
DISCUSSION: A RMS differences between systems A, B, C, D, and E appear due primarily to bias in the lower span, though magnitude was laboratory-dependent. Possible residual differences between laboratory procedures may affect the local biases at the lower saturations. Relative system bias curves were consistent across labs, suggesting A RMS differences may relate to the subjects, subject management, and/or blood sampling and analysis. Further investigation is indicated. reason, the development of the tracheotomy endoscope was started (2) . Injuries to the posterior tracheal wall are serious and potentially fatal complications of percutaneous tracheostomy. STEIN found a 7% incidence of injuries, 2% of which were perforating injuries that required invasive thoracic surgery (3). Dost and Koeser (4), reporting the results of a recent survey in Germany, documented six posterior wall injuries and seven tracheoesophageal fistulas. In a review of the literature, Oeken et al. (5) found 40 severe posterior wall injuries and 28 cases of pneumothorax. Delank et al. (6) report on five post-PDT lesions requiring operative treatment. Stein (5) found an 18% incidence of cartilage fractures under endoscopic control, and he found 15 fractures in 21 cases that were autopsied after PDT. Frova and Quintel (7) report an 8% incidence of cartilage fractures using Percu Twist® screw. Ambesh et al. (8) cite a 30% incidence of tracheal ring fractures using PDT.
CONCLUSION: Spo 2 accuracy varies between pulse oximeter systems as independently observed at different laboratory facilities, particularly at low Sao 2 . Specific
METHOD:
The new tracheostomy endoscope (TED) is designed to help prevent serious complications in dilatational tracheotomies and facilitate their management (2) . The method is based on the principle of ventilation laryngoscopy (VLS) described by Fabian and Brandt in 1964 -1965 (9,10) . The new endoscope (TED) has been specifically adapted to meet the requirements of percutaneous dilatational tracheotomies. It is fully compatible with all current techniques of PDT. The projecting posterior lip of the tracheotomy endoscope prevents inadvertent puncture of the posterior tracheal wall. The prismatic light deflector provides a maximum illumination. Optimal puncture site is marked by transillumination with a curved fiberoptic light carrier inserted through the endoscope. Different ventilation modes are possible with the tracheotomy endoscope: Jet ventilation via built-in jet channels and manual bag ventilation. The endoscope has a built-in CO 2 measurement channel. The endoscope is CE-certified (CE 0123).
RESULTS
: Large blood vessels in the anterior part of the neck are clearly outlined by the transilluminating effect of the tracheotomy endoscope. Use of the tracheotomy endoscope eliminates the familiar problem of flexible endoscopes narrowing the lumen of endotracheal tube, making it necessary to interrupt the tracheotomy to optimize ventilation. This can be particularly troublesome in critical care patients with a small-diameter indwelling tube. Because flexible endoscopes are not suitable for either the visualization or treatment of heavy bleeding, a rigid endoscope during PDT allows blood removal with large-diameter suction tubes. Bleeding into the trachea can be safely controlled under good endoscopic vision using sturdy metal insulated suction cannula and coagulating tubes. Displaced cartilage fracture fragments can be immediately repositioned endoscopically, and smaller fragments or tissue debris can be removed. This eliminates the risk that displaced fragments may become epithelialized and narrow the tracheal lumen (2) . CONCLUSION: Experiences in clinical application and first results of a pilot study confirm positive expectations that tracheotomy endoscope increases the standard of safety in PDT.
End-Tidal CO 2 Measurements with Noninvasive Ventilation
Paul Nuccio, RRT, FAARC,* Gary Hochstetler, RRT, † and Michael Jackson, RRT-NPS, CPFT ‡ From the *Brigham and Women's Hospital, Boston, Massachusetts; †Independent Consultant; and ‡Independent Consultant, Boston, Massachusetts
STUDY OBJECTIVE: To understand the technical aspects of measuring end-tidal CO 2 (Etco 2 ) in the noninvasively ventilated (NIV) patient. A laboratory study was conducted to compare simultaneous Etco 2 data from three different sample sites with commonly used patient interfaces, NIV modes, and varying patient leak rates.
DESIGN: Minute ventilation (MV) and Etco 2 readings were collected simultaneously at three different sample sites with commonly used clinical pressure settings and modes. Two types of full-face masks were used: 1) no expiratory ports in the mask (FFNP) (Respironics), 2) expiratory ports in the mask (FFEP) (Fisher Paykel).
SETTING: Laboratory.
METHODS: Etco 2 measurements were collected using Microcap (Oridion) microstream capnographs. Sample sites were 1) nasal/oral sample line (NO) (Smart CapnoLine H Plus, Oridion), 2) sample port (SP) on the mask, and 3) sample line at the ventilator tubing and mask connection (MC) point. A noninvasive ventilator (BiPAP Vision, Respironics) was used to deliver commonly used settings in CPAP and spontaneous timed (ST) modes. The three Etco 2 site readings were taken at two different patient leak (PL) levels for each mode and pressure settings.
RESULTS:
The data revealed there were significant variations in Etco 2 results at the different sample sites. The nasal/oral (NO) sample site was very consistent throughout all settings and patient leak rates.
In the ST mode the nasal/oral (NO) sample site was more reliable for appropriate Etco 2 readings at different ventilator settings and patient leaks.
CONCLUSION:
The sampling site for CO 2 in NIV can greatly influence the reliability of the Etco 2 value. The nasal/oral (NO) sample line proved to be the most reliable in trending Etco 2 with different ventilator modes, settings, and leak rates in the normal patient. METHODS: Three patients where monitored postoperatively using pulse oximetry (Spo 2 ) and end-tidal carbon dioxide (Etco 2 ), capnography, as part of that experience. Alarm limits were set per hospital protocol. Clinicians were alerted to respiratory depression when those alarms were activated.
Making Pain Management Safer Using Capnography: Three cases
RESULTS:
All patients experienced respiratory compromise. Patients were determined to have impending respiratory compromise by Etco 2 before alert by the Spo 2 alarm conditions being activated. Patient 1 was evaluated as having respiratory depression due to previously unrecognized obstruction sleep apnea, secondary to obesity with an elevated Etco 2 of 74 and normal (90% or greater) Spo 2 . Patient was treated and referred to the sleep lab for further diagnostics. Patient 2 was noted to have medication induced respiratory depression with a normal Spo 2 and decreasing respiratory rate, Etco 2 alarm occurred at 8 bpm and appropriate intervention was taken. Patient 3 was noted to have a no breath alarm via Etco 2 with normal Spo 2 and determined to have OSA with a subsequent referral to the sleep laboratory for further evaluation.
DISCUSSION: Etco 2 is the first indicator of respiratory depression in all patients in the series. Etco 2 alarms activated before Spo 2 alarms. Undiagnosed OSA was prevalent in these patients receiving postoperative analgesia for pain management. One patient required direct control of analgesia whereupon respiratory patterns returned to acceptable levels. All three patients experienced respiratory compromise, with normal Spo 2 . These dysfunctions may have gone unrecognized or progressed to a more serious level without the use of capnography to monitor ventilation.
CONCLUSION:
Reliance on Spo 2 as the primary indicator of respiratory status may not be adequate for patients at risk during PCA. Capnography is a measurement of ventilation and in this series gave advance notice of impending respiratory demise. Elimination of carbon dioxide is a function of ventilation and should be considered a primary monitoring tool of respiratory function. In this series, all PCA patients experienced a positive benefit through the incorporation of real time measurement of Etco 2 . CPAP level  5  5  10  10  5  5  10  10  PL  10  20  10  22  32  60  34  80  M V  7  5  7  6  6  6  6  6  Etco 2 NO  30  32  31  32  32  30  31  29  Etco 2 SP  33  23  27  22  14  20  12  14  Etco 2 MC  2 9  1 3  2 Based on photometric analysis of optical determination of parameters in whole blood, a photometric device (PMD) has been developed, which allows an exact, noninvasive online ctHb and sO 2 measurement. The sensor is designed to measure at the finger site and in a tube. This device is applicable in clinical areas where blood is taken from the body via a drainage system and in the near future for application on patients noninvasively.
CPAP data
Mask type FFNP FFNP FFNP FFNP FFEP FFEP FFEP FFEP
To determine the influence of sO 2 , temperature (T), and the pH-value on ctHb progression an in vitro model was developed to demonstrate the correlation of invasively and noninvasively measured data of ctHb.
METHODS:
The spectrum of whole blood in the visible and near infrared range is dominated by the absorption of hemoglobin, its derivatives and plasma. The principle the PMD uses is based on wavelength selective light absorption of whole blood. The device contains five-time multiplexed pulsed lasers diodes of different wavelengths (670, 808, 905, 980, and 1310 nm). The laser light is guided via fiber optics and a custom-built optic to the sensor head, which is designed to fit the tube. After the light interacts with the blood the transmitted signal is analyzed and the absorption coefficients of sO 2 and ctHb are calculated (1, 2) .
By measuring at wavelength k ,k ϭ 1, . . . ,K the values R k are obtained, which satisfy the equation The elements of the matrix A are the absorption coefficients of oxygenated and deoxygenated hemoglobin in the erythrocytes as well as in plasma of whole blood at wavelength k . The hemoglobin concentration can be obtained by solving the above linear equation.
The sensor was attached to a flexible silicone tube with a defined outer diameter of 0.17 in. The PMD has been verified in a hemodynamic model driven by a roller pump, which allows variation of blood parameters. A continuously moved blood bag served as a reservoir for the mixture of blood and plasma of a defined ratio to adjust ctHb. The integrated oxygenator allows a variation of the degree of oxygen saturation and the blood temperature (Table 1 ). Blood probes were sampled near the sensor and analyzed by a blood gas analyzer (ABL 725, Radiometer Copenhagen; Denmark).
The model allows a simulation of a steady (DC modus) and a pulsatile blood flow (AC modus) while the parameters to be measured have been changed separately or simultaneously. Tests were performed for both modes where sO 2 was changed and ctHb decreased. The precision as the standard deviation of the residuals (SDR) and the accuracy A rms (root-mean-square difference between measured and reference values) for the ctHb were calculated.
RESULTS:
Oxygen saturation was varied on the claimed ctHb levels and vice versa with this in vitro model. Although the temperature was held constant, the change of the pH-value led to no further effect on the measurements of sO 2 and ctHb. Based on the signal extraction, the measured values in the DC modus exhibit a lower variance than in the AC modus ( Table 2) .
DISCUSSION:
The PMD seems to be able to follow the hemoglobin concentrations in a tube noninvasively in the AC and DC modus.
Indirect Calorimetry System Based on Luminescence Quenching On-Airway Oxygen Sensor
Joseph Orr, PhD From the Bioengineering Laboratory, Department of Anesthesiology, University of Utah, Utah
INTRODUCTION:
We evaluated an indirect calorimetry system that uses an on-airway oxygen sensor based on the photoluminescence quenching principle.
Indirect calorimetry calculates metabolic rate and calorie consumption from directly measured oxygen uptake (VO 2 ) and carbon dioxide production (VCO 2 ). These systems measure the difference in volume or inspired and expired O 2 and CO 2 in respiratory gases. Most indirect calorimetry systems designed for use in critical care use sampling paramagnetic oxygen analyzers. Side sampling introduces challenges including signal alignment with the flow measurement, sampling tube occlusion and others.
METHODS:
We used a patient simulator based on propane combustion to model oxygen uptake (VO 2 ) and CO 2 production (VCO 2 ). We compared the VCO 2 , VO 2 , and respiratory quotient as measured by the on-airway system with the standard paramagnetic oxygen sensor type metabolic analyzer (Deltatrac, Datex, Helsinki, Finland). The respiratory quotient (RQ) is the ratio of CO 2 production to oxygen consumption. Because the simulator burns propane gas, we know that the true respiratory quotient (RQ) should always be 0.6. On the basis of earlier studies (1), we assumed that the VCO 2 measurements for both systems were accurate. We then calculated the true reference VO 2 for each setting from the measured VCO 2 and the known RQ.
We ventilated the patient simulator using a Siemens 900C ventilator at two simulated metabolic rates using three inspired O 2 (Fio 2 ) levels at each simulated metabolic rate. The measured VO 2 and VCO 2 should have been the same at each simulated metabolic rate regardless of the inspired oxygen concentration. The measurements (Fio 2 , VCO 2 , and VO 2 ) were recorded as they were reported in real time. Fio 2 , VO 2 , and VCO 2 were recorded and compared for both monitors. The VO 2 results were also compared to the ideal VO 2 measurement calculated using the measured VCO 2 and the known RQ of 0.6.
Parameters and Range
RESULTS:
The average difference in CO 2 production between the two systems was 0.5 Ϯ 3.9 mL/min. The average percent difference was 0.3% Ϯ 2.8%. The data plot below shows that the inspired oxygen (Fio 2 ) measurements correlated well (r 2 ϭ 0.999). The average oxygen consumption (VO 2 ) error for the Deltatrac monitor was 23 Ϯ 50 mL/min (5.8% Ϯ 13.9%). The average error for the on-airway, luminescence quenching system was Ϫ13 Ϯ 2.5 mL/min (Ϫ5.4% Ϯ 1.3%). The VO 2 measurement error using the on-airway system was consistently small across all inspired oxygen levels. The Deltatrac system showed a definite correlation between percent measurement error and the inspired oxygen concentration. Melendez et al. (2) found that the Deltatrac tends to measure VO 2 too high when the Fio 2 is increased.
CONCLUSION: Accurate measurement of oxygen consumption is one of the most challenging applications of respiratory oxygen monitoring. Our data shows that an on-airway oxygen analyzer based on luminescence quenching can be applied to provide accurate oxygen uptake measurements.
From the *Anaesthetic Laboratory, St. Bartholomew's Hospital; and †School of Engineering and Mathematical Sciences, City University, London, UK
INTRODUCTION: Management of patients after major neurosurgical procedures, particularly in the days after traumatic head injury, aims to prevent secondary damage. Raised intracranial pressure (ICP) due to swelling of the brain can reduce blood flow and can lead to compromised delivery of oxygen to the brain tissue (1) . For many years, management of patients at serious risk of raised intracranial pressure has included intracranial pressure monitoring via a cranial bolt inserted into a burr hole drilled through the skull (2) . We have developed an optical fiber probe, which may be inserted via a cranial bolt, allowing oxygen saturation measurements to be made from the blood vessels within the brain tissue. A preliminary study was undertaken to determine whether photoplethysmographic (PPG) signals could be obtained from the brain tissue and to determine the optimal optical fiber characteristics and depth of penetration of the fibers into the brain.
METHODS:
The probe consists of two silica optical fibers with a core diameter of 400 m and a numerical aperture (NA) of 0.39. Each fiber is terminated at one end with an SMA connector and the other end is cut and polished flat. The instrumentation is housed in a metal box containing: red (660 nm) and infrared (850 nm) emitters, a PIN photodiode photodetector, a battery power supply, and a simple signal processing circuit. The signals for each of the two wavelengths are recorded and stored on a notebook computer using a LabVIEW-based data acquisition system (3). This study was approved by the local Research Ethics Committee (Investigational Review Board) and patients' written informed consent was sought before the study. Patients who required cranial bolts as part of their routine neurosurgical care were recruited. After induction of anesthesia, the cranial bolt was inserted by the neurosurgeon. The fibers were inserted via the bolt, 5 mm into the brain and PPG signals recorded for 4 min. The fibers were then removed and the surgery resumed.
RESULTS:
To date, five patients have been studied. Signals were successfully obtained at both wavelengths for all five patients, and 0.39 NA fibers performed better than 0.22 NA fibers. Figure 1 shows a sample of the infrared ac PPG waveform recorded from one patient. The PPG signals consisted of variations in intensity consistent with the cardiac frequency. In some patients, the PPG signal was modulated by a periodic signal of very large amplitude occurring at the respiratory frequency. This signal was thought to be caused by the ventilatorinduced pressure changes in the cerebral circulation.
DISCUSSION:
We have shown that good quality red and near-infrared PPG signals could be obtained directly from human brain tissue using a fiber optic probe. The 0.39 NA optical fibers and 5 mm depth of penetration appear appropriate for signal acquisition. This proofof-concept study warrants further evaluation of the PPG brain probe to establish whether signal quality can be maintained for a clinically relevant monitoring period, and to correlate this method with other observations.
Pulse Oxigraphy: A Noncontact Imaging Approach
F.P. Wieringa,* † F. Mastik,* A. Dumay, † and A.F.W. van der Steen* ‡ From the *Erasmus MC Thorax Centre Rotterdam, Netherlands; †TNO Quality of Life, Leiden, Netherlands; and ‡Interuniversitary Cardiology Institute, Netherlands
BACKGROUND: After its invention in 1974 by Aoyagi, pulse oximetry rapidly became an important vital monitoring sign. In medical history, each vital monitoring sign (i.e., heart rate, respiratory rate, temperature, blood pressure, and arterial oxygen saturation) considerably increased insights in normal and pathological physiology.
As the word "insight" illustrates, human perception matches better with images than numbers (thermography, e.g., helps understanding temperature household).
Infrared ac-filtered normalized PPG signals recorded from the brain tissue via a cranial bolt, with pulse rate 80 bpm, and superimposed ventilation artifact at 13 ventilations per minute. Likewise, viewing tissue oxygenation images might offer added value compared with "single point" pulse oximetry. Hence, we conceived a noncontact optical method to visualize arterial oxygen saturation distribution. It is based upon pixel-to-pixel matched camera movies in three spectral bands (660, 810, and 940 nm). For all three wavelengths, position-dependent photoplethysmograms are calculated. Then, applying the ratio-of-ratios method to the 660 and 940 nm signals, oxygen saturation levels are assigned to these positions. The images obtained at the 810 nm isobestic wavelength contain no oxygen information. They do, however, contain all artifacts like reflections, shadows, etc., which facilitates application as a reference. We describe an overview of our work in relation to this Spo 2 -imaging concept.
METHODS:
A. With a monochrome CMOS-camera with apochromatic lens and 3-LED-ringlight (100 LEDs Ϫ1 ), we acquired in vivo movies (duration 57 s; 13.7 frames per second) at three wavelengths while simultaneously recording ECG, respiration, and pulse oximeter pleth-wave (Nellcor N200). Movies were processed by dividing each image frame into discrete regions of interest (ROIs) averaging 10 ϫ 10 raw pixels each. For each ROI, pulsatile variation over time was assigned to a matrix of 3072 ROI-pixel time traces with individual Fourier spectra. B. Using the same camera and ringlight, in vitro camera-derived results (n ϭ 116, 3 blood pools, Ն9 oxygenation setpoints/pool, and 4 heart rates/setpoint) were obtained from a heart-lung machine perfused phantom's central region (placed at 22 cm distance in a light-tight enclosure) and, using a third-order least-squares spline approximation fit, were compared with reflectance-mode pulse oximetry (Nellcor N200, n ϭ 116) as well as with laboratory analysis (Radiometer ABL725, n ϭ 29, 3 blood pools and Ն9 setpoints per pool).
RESULTS:
A. Fourier spectra of all three wavelengths showed that cameraderived signals matched well with the respiration reference signal peak as well as with the fundamental heartbeat frequency and its first harmonic. Pulse-oximeter plethysmograms showed a large DC-offset but no distinct respiration-matched peak. B. Camera-derived results showed monotone and reproducible relations with pulse oximetry and laboratory values. However, pulse oximeter readings decreased about a factor 4 steeper than laboratory values when lowering the saturation setpoint. Therefore, the horizontal scales in Figures 1A and B differ.
CONCLUSIONS:
A. In vivo camera-derived photoplethysmograms at the wavelengths required for our concept could be derived, but with insufficient signal-to-noise ratio to calculate oxygen saturation. B. In vitro camera-results demonstrate the feasibility of the pulse oxigraphic principle.
Capnography During Sleep Apnea Using a Novel Mainstream Capnometer
S. Yamamori,* and Y. Takasaki † From the *Sensor Department, Nihon Kohden Corp., Tokyo, Japan; and †Center for Sleep Disorders, Ohta General Hospital, Fukushima, Japan
INTRODUCTION: Apnea detected by capnography is defined as no detection of CO 2 for 10, 20, or 30 s. However, capnography during sleep apnea sometimes shows abnormal capnograms. To better measure this, we developed a small mainstream capnometer (cap-ONE, Nihon Kohden Corp., Tokyo Japan) that fits under the nose of nonintubated patients. Previously, we reported that cap-ONE, which does not need aspiration of expired gas, can reliably measure capnography during both nasal and oral breathing (1, 2) . In this study, we examine capnograms obtained by cap-ONE during sleep apnea.
METHODS:
The cap-ONE consisted of an infrared light unit, an infrared detector unit, and a nasal adaptor, which collects expired gas. The nasal and oral gases were expired directly into the cap-ONE through the nasal tube and mouth guide of the nasal adaptor, respectively, to measure capnography. We recorded both polysomnography (PSG) and capnography for five patients with sleep disorder and examined 193 apnea events that were detected with PSG.
RESULTS AND DISCUSSION:
The table lists the number of capnograms during apnea events in each category. Expired CO 2 was shown in the capnograms of 40% of all apnea events in PSG. Small ripples were sometimes superimposed on the prolonged elevated capnogram during obstructive apnea (Fig. 1) . The peaks of the ripples indicate that patients can exhale briefly and intermittently. Shallow valleys between the peaks indicate slight or no inhaling due to airway obstruction. The cap-ONE can measure this because expired gas remains in the cap-ONE until inhaling starts. Sidestream capnometers cannot measure this because they need continuous aspiration of expired gas and the remaining expired gas is easily diluted with the air. Sidestream capnometers may incorrectly show deep valleys in the capnogram as if the patient can inhale during the obstructive apnea. The cap-ONE sometimes detected expired CO 2 as irregular capnograms in shallow breathing that is difficult to detect with conventional nasal pressure transducers or thermistors.
CONCLUSION:
In polysomnography, the cap-ONE can reveal much more precisely how each respiratory event happens in a patient with sleep apnea.
INTRODUCTION:
We developed a two-dimensional pulsation model of pulse oximetry. Instead of a one-dimensional single layer as in the conventional theory, the arteries pulsate in two dimensions taking 
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MODEL:
The arteries are modeled with a rectangular cross-section with horizontal width of W a and vertical thickness (optical pathlength) l a . Tissues outside of the artery are in an area lateral to the artery with width of W T and the same thickness as the artery. Assuming the input optical power illuminates the artery and the tissue uniformly, the transmitted power, P, is composed of two parts, one that passes through the artery and one that does not. When the artery pulsates, the optical pathlength and the widths of the artery and the tissue change simultaneously. As a result, we derived the following equation for the relative change of transmitted optical power, equivalent to the change of optical density, dA, in the conventional theory.
dA ϭ dP P ϭ Ϫ exp( Ϫ g T l a ) Ϫ exp( Ϫ g a l a )(1 Ϫ g a l a ) W r exp( Ϫ g T l a ) ϩ exp(g a l a ) dl a l a .
In the equation, W r ϭ W T /W a is the ratio of the widths of the two areas, g T is the extinction of tissues outside the artery, and g a the extinction of the artery due to O 2 Hb and RHb absorptions, the blood oxygen saturation s, and scattering of the blood. The ratio, R, of dA at two different wavelengths, where the relative pathlength change, dl a /l a , is cancelled, is a function of s, and this function defines the calibration curve, R-Spo 2 . In R, we have two parameters, l a and W r , that are not present in the conventional model and that represent human variations.
RESULTS: Data sets (ϫ) of R-Spo 2 of 13 human subjects were collected at wavelengths of 658 and 939 nm. Computer simulations of this two-dimensional pulsation model (solid line -) and the conventional one-dimensional pulsation model with (dashed line ---) and without (dotted line -) scattering were done at the same wavelengths as shown in the figure. In the simulation, l a ϭ 0.8 cm and W r ϭ 0.5.
CONCLUSIONS:
The two-dimensional pulsation model gives a specific form of effects of tissue outside the arteries in pulse oximetry. This model provides us the theoretical calibration curve that more closely matches the empirical data than the conventional model and can extend to very low saturation. 
